- Impact Factor: 2.389
- Indexed In: Clarivate Analytics: Science Citation Index, PubMed/MEDLINE, PubMed Central
- Publication is subject to payment of an article processing charge (APC)
- Submit here
Clinical and Applied Thrombosis/Hemostasis (CATH) is a peer-reviewed open access journal which focuses on the practical clinical and laboratory issues involved in managing bleeding and clotting disorders, especially those related to thrombosis, hemostasis, and vascular disorders. Please see the Aims and Scope tab for further information.
This journal is a member of the Committee on Publication Ethics (COPE).
This journal flipped to open access on August 1, 2017.
Submit your manuscript today at https://mc.manuscriptcentral.com/cath.
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Open access article processing charge (APC) information
Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons license.
The APC for this journal is currently 2400 USD.
The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.
Please direct any queries to firstname.lastname@example.org.
This journal changed its publication mode from subscription to open access in 2018.
Clinical and Applied Thrombosis/Hemostasis (CATH) is an open access, peer reviewed journal which is dedicated to serving as a forum for studies regarding the etiology, pathophysiology, clinical diagnosis, laboratory diagnosis, and treatment of thrombohemorrhagic disorders.
Articles dealing with new diagnostic procedures are encouraged, provided they are clinically oriented or potentially applicable to clinical and laboratory medicine. Articles dealing with all aspects of thrombosis, hemostasis, and vascular disorders of clinical or clinical laboratory applicability are also encouraged. The contents of the journal appeal to any person interested in clinical and applied thrombohemorrhagic disorders.
|Charles A. Carter, PharmD, MBA||Campbell University, Buies Creek, NC, USA|
|Jawed Fareed, Ph.D||Loyola University Chicago, USA|
|Esteban Gandara||The Ottowa Hospital, General Campus, Canada|
|Hua He||Beijing Anzhen Hospital, China|
|Deborah Hoppensteadt, Ph.D||Loyola University Chicago, USA|
|Walter Jeske, Ph.D||Loyola University Medical Center, Maywood, IL, USA|
|Nicos Labropoulos||Stony Brook University Medical Center, Stony Brook, NY, USA|
|Qing Ma, PharmD, PhD||University at Buffalo, Buffalo, NY, USA|
|Eduardo Ramacciotti, MD, PhD||Hospital e Maternidade Dr Christóvão da Gama, Sao Paulo, Brazil|
|Hideo Wada, M.D.||Mie University, Japan|
|Jeanine M. Walenga, Ph.D||Loyola University Medical Center, Maywood, IL, USA|
|Antonio Girolami, M.D.||University of Padua, Italy|
|Sylvia Haas, MD||Munich, Germany|
|Wolfgang Miesbach||Universitätsklinikum Frankfurt, Germany|
|Muzaffer Demir, M.D.||Trakya University, Turkey|
|Raul Altman, M.D.||Buenos Aires, Argentina|
|H. Peter Bacher, M.D., Ph.D||Long Grove, IL, USA|
|Gianni Belcaro, M.D., Ph.D||Pelcara, Italy|
|Samuel Berkman, M.D., FACP||Bevery Hills, CA, USA|
|Genmao Cao, M.D.||Shanxi Medical University, Taiyuan, China|
|Anthony K. Chan||McMaster University, Canada|
|Sergio Coccheri||Bologna, Italy|
|Charles J. Glueck, M.D.||Cholesterol Center, ABC Building|
|Mohammad Jamshidi, DO, FACS||Millennia Care Clinic, TX, USA|
|Valery Leytin, Ph.D||St. Michael’s Hospital, Toronto, Canada|
|Charles Mahan, PharmD, PhC||University of New Mexico, Albuquerque, NM, USA|
|Dimitri P. Mikhailidis, M.D., FRCPATH||Royal Free and University College Medical School, London, UK|
|Michael Mosesson, M.D.||University of Wisconsin, USA|
|Andrew N. Nicolaides||London, UK|
|William F. Pope||Dallas, TX, USA|
|Arthur Sasahara, M.D.||Boston, MA, USA|
|Georg-Friedrich von Tempelhoff, M.D.||City Hospital of Ruesselshein, Germany|
|David H. Van Thiel, M.D.|
|Russell D. Hull, MBBS, MSc, FRCP(C), PACP||Alberta, Canada|
This Journal is a member of the Committee on Publication Ethics.
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing,
and Publication of Scholarly Work in Medical Journals formulated by the International Committee of
Medical Journal Editors (ICMJE).
Please read the guidelines below then visit the journal’s submission site
https://mc.manuscriptcentral.com/cath to upload your manuscript. Please note that manuscripts not
conforming to these guidelines may be returned.
SAGE Publishing disseminates high-quality research and engaged scholarship globally, and we are committed to diversity and inclusion in publishing. We encourage submissions from a diverse range of authors from across all countries and backgrounds.
Only manuscripts of sufficient quality that meet the aims and scope of Clinical and Applied
Thrombosis/Hemostasis will be reviewed.
As part of the submission process you will be required to warrant that you are submitting your original
work, that you have the rights in the work, that you are submitting the work for first publication in the
Journal and that it is not being considered for publication elsewhere and has not already been published
elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of
any copyright works not owned by you.
If you have any questions about publishing with SAGE, please visit the SAGE Journal Solutions Portal
Please note: Beginning January 1, 2022 the APC for CAT will be $2400 USD. This APC will apply to papers with original submission dates of Jan 1, 2022 onward.
Please Read the Manuscript Submission Guidelines below before submitting your manuscript here:
- Open Access
- Article processing charge (APC)
- What do we publish?
3.1 Aims & scope
3.2 Article types
3.3 Writing your paper
3.3.1 Making your article discoverable
- Editorial policies
4.1 Peer Review Policy
4.3.1 Writing assistance
4.5 Declaration of conflicting interests
4.6 Research ethics and patient consent
4.7 Clinical Trials
4.8 Reporting guidelines
4.9 Research Data
- Publishing policies
5.1 Publication ethics
5.2 Contributor's publishing agreement
- Preparing your manuscript
6.1 Word processing formats
6.2 Artwork, figures and other graphics
6.3 Supplemental material
6.4 Reference style
6.5 English language editing services
- Submitting your manuscript
7.1 How to submit your manuscript
7.2 Title, keywords and abstracts
7.3 Information required for completing your submission
7.5 Information required for completing your submission
- On acceptance and publication
8.1 SAGE Production
8.2 Continuous publication
8.3 Promoting your article
- Further information
Clinical and Applied Thrombosis/Hemostasis is an open access, peer-reviewed journal. Each article
accepted by peer review is made freely available online immediately upon publication, is published
under a Creative Commons license and will be hosted online in perpetuity. Publication costs of the
journal are covered by the collection of article processing charges which are paid by the funder,
institution or author of each manuscript upon acceptance. There is no charge for submitting a paper to
If, after peer review, your manuscript is accepted for publication, a one-time article processing charge
(APC) is payable. This APC covers the cost of publication and ensures that your article will be freely
available online in perpetuity under a Creative Commons licence.
Please note: Beginning January 1, 2022 the APC for CAT will be $2400 USD. This APC will apply to papers with original submission dates of Jan 1, 2022 onward.
Before submitting your manuscript to Clinical and Applied Thrombosis/Hemostasis, please
ensure you have read the Aims & Scope.
- Original Manuscripts
- Letters to the Editor*
- Supplemental Article
- Book Review
*A letter to the Editor is a brief communication that either addresses the contents of a published
article, or is a correspondence unrelated to a specific article. Its purpose is to make corrections,
provide alternative viewpoints, or offer counter arguments. Avoid logical fallacies and ad
hominem attacks. Letters to the Editor must be written in a professional tone and include
references to support all claims if appropriate.
A letter to the Editor unrelated to a specific article should not exceed 500 words or have more
han 3 references. A letter to the Editor pertaining to a recently published article or to be
published concurrently with an article within the journal should not exceed 800 words or have
more than 5 references. If an abstract is included, it will automatically be made the first
paragraph. Letters should not include figures or research material. Letters to the editor are
not charged an APC.
Authors are encouraged to submit review/original manuscripts that are not under consideration
for publication elsewhere to the Journal for review.
Manuscript Preparation. Manuscripts should be double-spaced with one-inch margins.
Headings must be used to designate the major divisions of the paper. Pages should be
numbered consecutively at the top of the manuscript. The surname of each author should
appear in the upper left corner of each page, followed by a brief running title.
Title Page. Page 1 should include the title followed by the names and degrees of all authors as
they will appear in print. This will be followed by a listing of the authors’ institutional affiliations.
The title page should also include the name, address, telephone number, e-mail, and fax
number of the corresponding author, and e-mail addresses for all co-authors. The author should
cite if the paper was presented orally at a professional meeting, including the name of the
meeting, date, and place. Credits and grant information supporting the research should also be
listed if this study was supported by an agency.
Abstract. The abstract should appear at the beginning of the manuscript and should be no
longer than 180 words in length. It should summarize the main points of the paper and be
descriptive, narrative, and informative.
Tables. Tables should be double-spaced on pages separate from the text. Number tables
consecutively with text and provide a table number and title for each. Hold length to one
standard-sized manuscript page if possible. If a table continues past one page, repeat all heads
and stub (left-hand) column. Tables should be numbered in order of citation in the text. Do not
use photocopy reduction. Data in tables should not duplicate material in the text or illustrations.
It is suggested to have no more than 3 tables and 5 figures.
Artwork. Figure files must be submitted as separate files and are not to be embedded within the
text file. Please use the following specifications for electronic figures:
- Authors are encouraged to use Adobe Illustrator and Adobe Photoshop to create
- Do not use Powerpoint or CorelDRAW. They print poorly on high-density printers.
JPEG and TIFF files are preferred.
- The resolution for print must be at least 300 CPI. Low-resolution graphics cannot be
References. Please visit the official website of the U.S. National Library of Medicine
http://www.nlm.nih.gov/bsd/uniform_requirements.html to see how references should be
The SAGE Author Gateway has some general advice and on how to get published, plus links to
When writing up your paper, think about how you can make it discoverable. The title,
keywords and abstract are key to ensuring readers find your article through search
engines such as Google. For information and guidance on how best to title your article,
write your abstract and select your keywords, have a look at this page on the Gateway:
How to Help Readers Find Your Article Online
The journal’s policy is to have manuscripts reviewed by two expert reviewers. Clinical and
Applied Thrombosis/Hemostasis utilizes a single-anonymize peer review process in which the
reviewer’s name and information is withheld from the author. All manuscripts are reviewed as
rapidly as possible, while maintaining rigor. Reviewers make comments to the author and
recommendations to the Editor-in-Chief who then makes the final decision.
As part of the submission process you will be asked to provide the names of 2 peers who could
be called upon to review your manuscript. Recommended reviewers should be experts in their
fields and should be able to provide an objective assessment of the manuscript. Please be aware
of any conflicts of interest when recommending reviewers. Examples of conflicts of interest
include (but are not limited to) the below:
• The reviewer should have no prior knowledge of your submission
• The reviewer should not have recently collaborated with any of the authors
• Reviewer nominees from the same institution as any of the authors are not permitted
You will also be asked to nominate peers who you do not wish to review your manuscript
Please note that the Editors are not obliged to invite any recommended/opposed reviewers to
assess your manuscript.
The Editor or members of the Editorial Board may occasionally submit their own manuscripts forpossible publication in the journal. In these cases, the peer review process will be managed by
alternative members of the Board and the submitting Editor / Board member will have no
involvement in the decision-making process.
The Editor or members of the Editorial Board may occasionally submit their own manuscripts for
possible publication in the journal. In these cases, the peer review process will be managed by
alternative members of the Board and the submitting Editor/Board member will have no
involvement in the decision-making process.
Papers should only be submitted for consideration once consent is given by all contributing
authors. Those submitting papers should carefully check that all those whose work contributed
to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all
(i) Made a substantial contribution to the concept or design of the work; or acquisition,
analysis or interpretation of data,
(ii) Drafted the article or revised it critically for important intellectual content,
(iii) Approved the version to be published,
(iv) Each author should have participated sufficiently in the work to take public
responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. Each author should have
participated sufficiently in the work to take public responsibility for appropriate portions of the
When a large, multicentre group has conducted the work, the group should identify the
individuals who accept direct responsibility for the manuscript. These individuals should fully
meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone
does not constitute authorship, although all contributors who do not meet the criteria for
authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on
All contributors who do not meet the criteria for authorship should be listed in an
Acknowledgements section. Examples of those who might be acknowledged include a person
who provided purely technical help, or a department chair who provided only general support.
4.3.1 Third party submissions
Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:
• Disclose this type of editorial assistance – including the individual’s name, company and level of input
• Identify any entities that paid for this assistance
• Confirm that the listed authors have authorized the submission of their manuscript via third party and approved any statements or declarations, e.g. conflicting interests, funding, etc.
Where appropriate, SAGE reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.
Individuals who provided writing assistance, e.g. from a specialist communications company, do
not qualify as authors and so should be included in the Acknowledgements section. Authors
must disclose any writing assistance – including the individual’s name, company and level of
input – and identify the entity that paid for this assistance.
It is not necessary to disclose use of language polishing services.
Any acknowledgements should appear first at the end of your article prior to your Declaration of
Conflicting Interests (if applicable), any notes and your References.
Clinical and Applied Thrombosis/Hemostasis requires all authors to acknowledge their funding in
a consistent fashion under a separate heading. Please visit the Funding Acknowledgements
page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in
the event of funding, or state that: This research received no specific grant from any funding
agency in the public, commercial, or not-for-profit sectors.
It is the policy of Clinical and Applied Thrombosis/Hemostasis to require a declaration of
conflicting interests from all authors enabling a statement to be carried within the paginated
pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of
your manuscript, after any acknowledgements and prior to the references. If no conflict exists,
please state that ‘The Author(s) declare(s) that there is no conflict of interest’.
For guidance on conflict of interest statements, please see the ICMJE recommendations.
Medical research involving human subjects must be conducted according to the World Medical
Association Declaration of Helsinki.
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct,
Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers
reporting animal and/or human studies must state in the methods section that the relevant
Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure
that you have provided the full name and institution of the review committee, in addition to the
For research articles, authors are also required to state in the methods section whether
participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in
the manuscript text. A statement is required regarding whether written informed consent for
patient information and images to be published was provided by the patient(s) or a legally
authorized representative. Please do not submit the patient’s actual written informed consent
with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that
you confirm to us, in writing, that you have obtained written informed consent but the written
consent itself should be held by the authors/investigators themselves, for example in a patient’s
hospital record. The confirmatory letter may be uploaded with your submission as a separate file.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants
All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The Journal has adopted the ARRIVE guidelines.
Clinical and Applied Thrombosis/Hemostasis endorses the ICMJE requirement that clinical trials
are registered in a WHO-approved public trials registry at or before the time of first patient
enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will
be considered if the justification for late registration is acceptable. The trial registry name and
URL, and registration number must be included at the end of the abstract.
The relevant EQUATOR Network reporting guidelines should be followed depending on the type
of study. For example, all randomized controlled trials submitted for publication should include
a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should
be uploaded with your submission as a supplementary file. Systematic reviews and metaanalyses
should include the completed PRISMA flow chart as a cited figure and the completed
PRISMA checklist should be uploaded with your submission as a supplementary file. The
EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.
The journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the SAGE Research Data policy pages.
Subject to appropriate ethical and legal considerations, authors are encouraged to:
- share your research data in a relevant public data repository
- include a data availability statement linking to your data. If it is not possible to share your data, we encourage you to consider using the statement to explain why it cannot be shared.
- cite this data in your research
SAGE is committed to upholding the integrity of the academic record. We encourage authors to
refer to the Committee on Publication Ethics’ International Standards for Authors and view the
Publication Ethics page on the SAGE Author Gateway.
Clinical and Applied Thrombosis/Hemostasis and SAGE take issues of copyright infringement,
plagiarism or other breaches of best practice in publication very seriously. We seek to protect
the rights of our authors and we always investigate claims of plagiarism or misuse of published
articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted
articles may be checked with duplication-checking software. Where an article, for example, is
found to have plagiarized other work or included third-party copyright material without
permission or with insufficient acknowledgement, or where the authorship of the article is
contested, we reserve the right to take action including, but not limited to: publishing an
erratum or corrigendum (correction); retracting the article; taking up the matter with the head
of department or dean of the author's institution and/or relevant academic bodies or societies;
or taking appropriate legal action.
5.1.2 Prior publication
If material has been previously published, it is not generally acceptable for publication in a SAGE
journal. However, there are certain circumstances where previously published material can be
considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in
doubt, contact the Editor at the address given below.
Before publication SAGE requires the author as the rights holder to sign a Journal Contributor’s
Publishing Agreement. Clinical and Applied Thrombosis/Hemostasis publishes manuscripts
under Creative Commons licenses. The standard license for the journal is Creative Commons by
Attribution Non-Commercial (CC BY-NC), which allows others to re-use the work without
permission as long as the work is properly referenced and the use is non-commercial. For more
information, you are advised to visit SAGE's OA licenses page.
Alternative license arrangements are available, for example, to meet particular funder
mandates, made at the author’s request.
The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and
(La)Tex templates are available on the Manuscript Submission Guidelines page of our Author
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please
visit SAGE’s Manuscript Submission Guidelines.
Figures supplied in color will appear in color online.
This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images
etc) alongside the full-text of the article. These will be subjected to peer-review alongside the
article. For more information please refer to our guidelines on submitting supplementary files,
which can be found within our Manuscript Submission Guidelines page.
Clinical and Applied Thrombosis/Hemostasis adheres to the American Medical Association
Manual of Style (9th Edition) for references. Key the references (double spaced) at the end of
the manuscript. Cite the references in text in the order of appearance. Cite unpublished data,
such as papers submitted but not yet accepted for publication or personal communications, in
parentheses in the text. If there are more than three authors, name only the first three authors
and then use et al. Refer to the List of Journals Indexed in Index Medicus for abbreviations of
journal names, or access the list at http://www.nlm.nih.gov/tsd/serials/lji.html.
Authors seeking assistance with English language editing, translation, or figure and manuscript
formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit
SAGE Language Services on our Journal Author Gateway for further information.
Clinical and Applied Thrombosis/Hemostasis is hosted on SAGE Track, a web based online
submission and peer review system powered by ScholarOne™ Manuscripts. Visit
https://mc.manuscriptcentral.com/cath to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to
create a new one. If you have reviewed or authored for the journal in the past year it is likely
that you will have had an account created. For further guidance on submitting your manuscript
online please visit ScholarOne Online Help.
Please supply a title, short title, an abstract and keywords to accompany your article. The title,
keywords and abstract are key to ensuring readers find your article online through online search
engines such as Google. Please refer to the information and guidance on how best to title your
article, write your abstract and select your keywords by visiting the SAGE Journal Author
Gateway for guidelines on How to Help Readers Find Your Article Online.
Provide full contact details for the corresponding author including email, mailing address and
telephone numbers. Academic affiliations are required for all co-authors. These details should
be presented separately to the main text of the article to facilitate anonymous peer review.
You will be asked to provide contact details and academic affiliations for all co-authors via the
submission system and identify who is to be the corresponding author. These details must
match what appears on your manuscript. At this stage please ensure you have included all the
required statements and declarations and uploaded any additional supplementary files
(including reporting guidelines where relevant).
As part of our commitment to ensuring an ethical, transparent and fair peer review process
SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID
provides a unique and persistent digital identifier that distinguishes researchers from every
other researcher, even those who share the same name, and, through integration in key
research workflows such as manuscript and grant submission, supports automated linkages
between researchers and their professional activities, ensuring that their work is recognized.
The collection of ORCID IDs from corresponding authors is now part of the submission
process of this journal. If you already have an ORCID iD you will be asked to associate that
to your submission during the online submission process. We also strongly encourage all
co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes
seconds to do: click the link when prompted, sign into your ORCID account and our systems are
automatically updated. Your ORCID iD will become part of your accepted publication’s metadata,
making your work attributable to you and only you. Your ORCID iD is published with your article
so that fellow researchers reading your work can link to your ORCID profile and from there link
to your other publications.
You will be asked to provide contact details and academic affiliations for all co-authors via the
submission system and identify who is to be the corresponding author. These details must match
what appears on your manuscript. The affiliation listed on the manuscript should be the institution
where the research was conducted. If an author has moved to a new institution since completing
the research, the new affiliation can be included in a manuscript note at the end of the paper. At
this stage please ensure you have included all the required statements and declarations and
uploaded any additional supplementary files (including reporting guidelines where relevant).
Authors are responsible for obtaining permission from copyright holders for reproducing any
illustrations, tables, figures or lengthy quotations previously published elsewhere. For further
information including guidance on fair dealing for criticism and review, please visit our
Frequently Asked Questions on the SAGE Journal Author Gateway.
If your paper is accepted for publication after peer review, you will first be asked to complete the
contributor’s publishing agreement. Once your manuscript files have been check for SAGE Production,
the corresponding author will be asked to pay the article processing charge (APC) via a payment link.
Once the APC has been processed, your article will be prepared for publication and can appear online
within an average of 30 days. Please note that no production work will occur on your paper until the
APC has been received.
Your SAGE Production Editor will keep you informed as to your article’s progress throughout the
production process. Proofs will made available to the corresponding author via our editing portal
SAGE Edit, or by email to the corresponding author and should be returned promptly. Authors are
reminded to check their proofs carefully to confirm that all author information, including names,
affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest
statements, if any, are accurate. Please note that if there are any changes to the author list at this
stage all authors will be required to complete and sign a form authorizing the change.
One of the many benefits of publishing your research in an open access journal is the speed to
publication. With no page count constraints, your article will be published online in a fully
citable form with a DOI number as soon as it has completed the production process. At this time
it will be completely free to view and download for all.
Publication is not the end of the process! You can help disseminate your paper and ensure it is
as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help
you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.
Any correspondence, queries or additional requests for information on the Manuscript Submission
process should be sent to the Clinical and Applied Thrombosis/Hemostasis editorial office as follows: